Arcus Biosciences RCUS
NYSE RCUS
$18.93 +0.65 (+3.56%)
At close: Nov 9, 2026 · 4:00 PM EST

Arcus Biosciences (RCUS) Equity Income (2018 - 2020)

Updated

Arcus Biosciences (RCUS) recorded Equity Income of -$613,000 in FY2020, compared with -$1.2 million in FY2019.

Analysis

Arcus Biosciences (RCUS) Equity Income (2018 - 2020) Analysis & Trends

Starting with FY2017, Arcus Biosciences' Equity Income history includes 4 years.

  • The FY2020 figure is the highest annual Equity Income since FY2017.
  • Per Business Quant data, RCUS's Equity Income was -$1.2 million in FY2019, -$886,000 in FY2018 and -$416,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -19.00 Mn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Arcus Biosciences 2.42 Bn -713.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 -131,000.00
Mar 31, 2020 -482,000.00
Sep 30, 2019 -357,000.00
Jun 30, 2019 -412,000.00
Mar 31, 2019 -431,000.00
Dec 31, 2018 -323,000.00
Sep 30, 2018 -186,000.00
Jun 30, 2018 -151,000.00
Mar 31, 2018 -226,000.00
API Access

Arcus Biosciences Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=RCUS&period=max&api_key=YOUR_API_KEY